Cyrus J. Lawrence’s Pfizer PFE Stock Holding History

Cyrus J. Lawrence’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-441	Closed	-$11K	–	128
2024 Q4	$11K	Sell	441 -1,533	-78%	-$41.6K	﹤0.01%	184
2024 Q3	$57K	Buy	1,974 +106	+6%	+$3.09K	0.01%	112
2024 Q2	$52K	Sell	1,868 -1,166	-38%	-$32.1K	0.01%	109
2024 Q1	$84K	Buy	+3,034	New	+$84.2K	0.02%	90
2023 Q3	$100K	Sell	3,034 -667	-18%	-$23.6K	0.03%	78
2023 Q2	$135K	Sell	3,701 -165,128	-98%	-$6.43M	0.03%	71
2023 Q1	$6.88M	Sell	168,829 -2,931	-2%	-$127K	2%	27
2022 Q4	$8.8M	Sell	171,760 -1,588	-0.9%	-$76.1K	2.63%	10
2022 Q3	$7.58M	Sell	173,348 -44,258	-20%	-$2.15M	1.49%	20
2022 Q2	$11.4M	Sell	217,606 -1,649	-0.8%	-$84K	3.29%	6
2022 Q1	$11.4M	Buy	+219,255	New	+$11.4M	2.6%	12

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cyrus J. Lawrence's PFE Position: Q1 2025 in Review

Cyrus J. Lawrence sold out of Pfizer (PFE) in Q1 2025, closing a stake of 441 shares — an estimated $11K sold.

Cyrus J. Lawrence first reported a position in PFE in Q1 2022 and held it in 11 quarters. The position peaked at $11.4M in Q2 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Cyrus J. Lawrence reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Cyrus J. Lawrence sold 441 Pfizer shares in Q1 2025, an estimated $11K.
Cyrus J. Lawrence first reported a position in Pfizer in Q1 2022 and held it in 11 quarters.
Cyrus J. Lawrence's Pfizer position peaked at $11.4M in Q2 2022.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Cyrus J. Lawrence's 13F filing for Q1 2025, filed 15 May 2025.